miRNA-205: a future therapeutic molecule for liver diseases
- PMID: 36908931
- PMCID: PMC9990095
- DOI: 10.4155/fdd-2022-0012
miRNA-205: a future therapeutic molecule for liver diseases
Keywords: chemotherapy; liver cancer; liver diseases; liver fibrosis; miRNA; nonalcohol fatty liver.
Conflict of interest statement
The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed
References
-
- Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J. Hepatol. 70(1), 151–171 (2019). - PubMed
-
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1), 73–84 (2016). - PubMed
-
- He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 21(11), 2785–2794 (2007). - PubMed
-
- Ling HY, Ou HS, Feng SD et al. CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin. Exp. Pharmacol. Physiol. 36(9), e32–39 (2009). - PubMed
Publication types
LinkOut - more resources
Full Text Sources